356 related articles for article (PubMed ID: 28077315)
1. Inhibition of iNOS alleviates cognitive deficits and depression in diabetic mice through downregulating the NO/sGC/cGMP/PKG signal pathway.
Zhou XY; Zhang F; Ying CJ; Chen J; Chen L; Dong J; Shi Y; Tang M; Hu XT; Pan ZH; Xu NN; Zheng KY; Tang RX; Song YJ
Behav Brain Res; 2017 Mar; 322(Pt A):70-82. PubMed ID: 28077315
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NF-κB activity by aminoguanidine alleviates neuroinflammation induced by hyperglycemia.
Song Y; Zhang F; Ying C; Kumar KA; Zhou X
Metab Brain Dis; 2017 Oct; 32(5):1627-1637. PubMed ID: 28634786
[TBL] [Abstract][Full Text] [Related]
3. Depression can be prevented by astaxanthin through inhibition of hippocampal inflammation in diabetic mice.
Zhou XY; Zhang F; Hu XT; Chen J; Tang RX; Zheng KY; Song YJ
Brain Res; 2017 Feb; 1657():262-268. PubMed ID: 28017669
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis.
Yan W; Pang M; Yu Y; Gou X; Si P; Zhawatibai A; Zhang Y; Zhang M; Guo T; Yi X; Chen L
Life Sci; 2019 Aug; 231():116566. PubMed ID: 31201846
[TBL] [Abstract][Full Text] [Related]
5. Astaxanthin improves cognitive deficits from oxidative stress, nitric oxide synthase and inflammation through upregulation of PI3K/Akt in diabetes rat.
Xu L; Zhu J; Yin W; Ding X
Int J Clin Exp Pathol; 2015; 8(6):6083-94. PubMed ID: 26261486
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of inflammation by astaxanthin alleviates cognition deficits in diabetic mice.
Zhou X; Zhang F; Hu X; Chen J; Wen X; Sun Y; Liu Y; Tang R; Zheng K; Song Y
Physiol Behav; 2015 Nov; 151():412-20. PubMed ID: 26272354
[TBL] [Abstract][Full Text] [Related]
7. Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes.
Rapôso C; Luna RL; Nunes AK; Thomé R; Peixoto CA
Brain Res Bull; 2014 May; 104():60-73. PubMed ID: 24727400
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like and neuroprotective effects of Aloysia gratissima: investigation of involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway.
Zeni AL; Zomkowski AD; Dal-Cim T; Maraschin M; Rodrigues AL; Tasca CI
J Ethnopharmacol; 2011 Sep; 137(1):864-74. PubMed ID: 21767626
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice.
Tomaz VS; Cordeiro RC; Costa AM; de Lucena DF; Nobre Júnior HV; de Sousa FC; Vasconcelos SM; Vale ML; Quevedo J; Macêdo D
Neuroscience; 2014 May; 268():236-46. PubMed ID: 24662848
[TBL] [Abstract][Full Text] [Related]
10. Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway.
Heydarpour P; Rahimian R; Fakhfouri G; Khoshkish S; Fakhraei N; Salehi-Sadaghiani M; Wang H; Abbasi A; Dehpour AR; Ghia JE
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():131-41. PubMed ID: 26268932
[TBL] [Abstract][Full Text] [Related]
11. Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway associated with peroxynitrite formation contributes to hypotension and vascular hyporeactivity in endotoxemic rats.
Korkmaz B; Buharalioglu K; Sahan-Firat S; Cuez T; Tuncay Demiryurek A; Tunctan B
Nitric Oxide; 2011 Apr; 24(3):160-72. PubMed ID: 21354320
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of Liuwei Dihuang decoction on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat.
Liu JP; Feng L; Zhang MH; Ma DY; Wang SY; Gu J; Fu Q; Qu R; Ma SP
J Ethnopharmacol; 2013 Oct; 150(1):371-81. PubMed ID: 24041458
[TBL] [Abstract][Full Text] [Related]
13. Zeaxanthin improves diabetes-induced cognitive deficit in rats through activiting PI3K/AKT signaling pathway.
Zhou X; Wang S; Ding X; Qin L; Mao Y; Chen L; Li W; Ying C
Brain Res Bull; 2017 Jun; 132():190-198. PubMed ID: 28599877
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
Palleria C; Leo A; Andreozzi F; Citraro R; Iannone M; Spiga R; Sesti G; Constanti A; De Sarro G; Arturi F; Russo E
Behav Brain Res; 2017 Mar; 321():157-169. PubMed ID: 28062257
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice.
Tanabe M; Nagatani Y; Saitoh K; Takasu K; Ono H
Neuropharmacology; 2009 Mar; 56(3):702-8. PubMed ID: 19111753
[TBL] [Abstract][Full Text] [Related]
16. Pinocembrin alleviates cognition deficits by inhibiting inflammation in diabetic mice.
Pei B; Sun J
J Neuroimmunol; 2018 Jan; 314():42-49. PubMed ID: 29150085
[TBL] [Abstract][Full Text] [Related]
17. Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice.
Xue M; Li T; Wang Y; Chang Y; Cheng Y; Lu Y; Liu X; Xu L; Li X; Yu X; Sun B; Chen L
Clin Sci (Lond); 2019 Aug; 133(15):1705-1720. PubMed ID: 31337673
[TBL] [Abstract][Full Text] [Related]
18. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test.
Jesse CR; Bortolatto CF; Savegnago L; Rocha JB; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1838-43. PubMed ID: 18773934
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence.
Montezuma K; Biojone C; Lisboa SF; Cunha FQ; Guimarães FS; Joca SR
Neuropharmacology; 2012 Jan; 62(1):485-91. PubMed ID: 21939674
[TBL] [Abstract][Full Text] [Related]
20. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences.
Kuhad A; Chopra K
Eur J Pharmacol; 2007 Dec; 576(1-3):34-42. PubMed ID: 17822693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
